GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Wall Street
Price Targets
GLAXO Price Targets Summary
GlaxoSmithKline Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
GLAXO
is 2 051.22 INR
with a low forecast of 1 504.9 INR and a high forecast of 2 572.5 INR.
Operating Income
Forecast
Operating Income Estimate
GlaxoSmithKline Pharmaceuticals Ltd
For the last 8 years the
compound annual growth rate for
GlaxoSmithKline Pharmaceuticals Ltd's operating income is
3%.
The projected
CAGR
for the next 3 years is
13%.
Net Income
Forecast
Net Income Estimate
GlaxoSmithKline Pharmaceuticals Ltd
For the last 8 years the
compound annual growth rate for
GlaxoSmithKline Pharmaceuticals Ltd's net income is
3%.
The projected
CAGR
for the next 3 years is
13%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GLAXO's stock price target?
Price Target
2 051.22
INR
According to Wall Street analysts, the average 1-year price target for
GLAXO
is 2 051.22 INR
with a low forecast of 1 504.9 INR and a high forecast of 2 572.5 INR.
What is GlaxoSmithKline Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
GlaxoSmithKline Pharmaceuticals Ltd's revenue is
0%.
The projected
CAGR
for the next 3 years is
8%.
What is GlaxoSmithKline Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
GlaxoSmithKline Pharmaceuticals Ltd's operating income is
3%.
The projected
CAGR
for the next 3 years is
13%.
What is GlaxoSmithKline Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
GlaxoSmithKline Pharmaceuticals Ltd's net income is
3%.
The projected
CAGR
for the next 3 years is
13%.
You don't have any saved screeners yet
